PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Cancer Research UK cuts fundings grants amid pandemic uncertainty

As of this morning – Tuesday April 7 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 51,608 with 5,373 deaths. Cancer Research UK (CRU...
Continue Reading →
News

Expanded EU approval for Takeda’s Alunbrig

European regulators have expanded the scope of Alunbrig (brigatinib) to include its use as a monotherapy for the treatment of adults with anaplastic lymphoma kinase-...
Continue Reading →
News

Oxford Biomedica joins consortium for promising COVID-19 vaccine

As of this morning – Wednesday April 8 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 55,242 with 6,159 deaths UK gene and cell the...
Continue Reading →
News

Outcome Health ramps efforts to help pharma with COVID-19 point-of-care messaging

Patients living with chronic conditions are still going to the doctor’s office despite COVID-19, because most really don’t have a choice. So Outcome Health is u...
Continue Reading →
News

AstraZeneca’s Imfinzi gets FDA green light to challenge Roche in small cell lung cancer

Move over, Roche. There’s a new small cell lung cancer therapy on the scene, and it belongs to AstraZeneca. Monday, the FDA cleared the British drugmaker’s Imfinzi...
Continue Reading →
News

Disaster at Amarin: Patent loss spurs stock spiral, but all hope might not be lost

Only months ago, hopes for Amarin, the maker of fish-oil derivative Vascepa, were sky-high after the FDA expanded the drug's label to include heart-helping language ...
Continue Reading →
News

Coronavirus tracker: Amgen, Genfit say they’re not expecting ‘significant’ trial delays, though others might

Amgen said it doesn’t expect any “significant delays” to the clinical development of its highly anticipated KRAS lung cancer drug—nor does Genfit with its NASH candi...
Continue Reading →
News

In response to COVID-19, ACG implements work from home policy, and takes other progressive measures to ensure workforce and public health

As a key pharma supply player, ACG is committed to working with its partners to ‘make the world healthier’. This means that of primary concern is the health of all p...
Continue Reading →
News

With its cargo operations, Turkish Cargo maintains the air bridge built by Turkish Airlines

As the global repercussions of the unprecedented situation caused by COVID-19 outbreak continues, Turkish Cargo, the global brand with the world’s sixth largest carg...
Continue Reading →
News

COVID-19: UK clinical tests to start next month as global authorities see spike in unauthorised meds

As the NHS announces a new major deal to expand hospital capacity to combat the spreading virus, clinical testing for vaccine candidates in the UK is being slated to...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026